Charikleia S Vrettou, Alice G Vassiliou, Chrysi Keskinidou, Panagiotis Mourelatos, Andreas Asimakos, Stavroula Spetsioti, Aristidis Diamantopoulos, Edison Jahaj, Archontoula Antonoglou, Paraskevi Katsaounou, Dimitra A Vassiliadi, Anastasia Kotanidou, Ioanna Dimopoulou
BACKGROUND: this prospective observational study aims to assess serum levels of glial fibrillary acidic protein (GFAP), s100b, and total Tau in long-COVID patients, exploring correlations with symptoms, cognitive decline, mental health, and quality of life. METHODS: Long-COVID patients visiting our outpatient clinic (February 2021-December 2022) were screened alongside age- and sex-matched controls. GFAP, s100b, and total Tau in serum were measured with ELISA. Cognitive function, depression, anxiety, post-traumatic stress disorder, and quality of life were evaluated using MoCA, HADS (depression and anxiety), IES-R, and SF-36, respectively...
March 16, 2024: Journal of Personalized Medicine